Does Metformin Interact with Betamethasone Sodium Phosphate Betamethasone Acetate Lidocai?
CDI records a major classification for Metformin and Betamethasone Sodium Phosphate Betamethasone Acetate Lidocai. The stored summary is: Iodixanol may increase risk of metformin-induced lactic acidosis, possibly by worsening renal function. Stop metformin before iodixanol administration in patients with renal impairment, hepatic impairment, alcoholism, or heart failure. The mechanism involves iodixanol may worsen renal function, increasing metformin accumulation and lactic acidosis risk. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Iodixanol may worsen renal function, increasing metformin accumulation and lactic acidosis risk
What To Tell Your Doctor or Pharmacist
If you are taking Metformin and your doctor is considering prescribing Betamethasone Sodium Phosphate Betamethasone Acetate Lidocai (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider